Ramanan , AV., Quartier , P., Okamoto , N., Foeldvari, I., Spindler, A., Fingerhutová , Š., Antón, J., Wang, Z., Meszaros, G., Araújo, J., Liao, R., Keller, S., Brunner, HI., Ruperto, N. & JUVE-BASIS investigators (2023).
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind placebo-controlled, withdrawal, efficacy, and safety trial.
Lancet,
402(10401), 555-570.
https://doi.org/10.1016/S0140-6736(23)00921-2
Lazarus, J. V., Mark, H. E., Allen, A. M., Arab, J. P., Carrieri, P., Noureddin, M., Alazawi, W., Alkhouri, N., Alqahtani, S. A., Arrese, M., Bataller, R., Berg, T., Brennan, P. N., Burra, P., Castro-Narro, G. E., Cortez-Pinto, H., Cusi, K., Dedes, N., Duseja, A. ... Healthy Livers, Healthy Lives Collaborators (2023).
A global research priority agenda to advance public health responses to fatty liver disease.
Journal of Hepatology,
79(3), 618-634.
https://doi.org/10.1016/j.jhep.2023.04.035
Kronborg, T. M., Schierwagen, R., Trošt, K., Gao, Q., Moritz, T., Bendtsen, F.
, Gantzel, R. H., Andersen, M. L., Teisner, A. S.
, Grønbæk, H., Hobolth, L., Møller, S., Trebicka, J. & Kimer, N. (2023).
Atorvastatin for patients with cirrhosis: A randomized, placebo-controlled trial.
Hepatology Communications,
7(12), Article e0332.
https://doi.org/10.1097/HC9.0000000000000332